Free equity investment tool of Japanese companies

HOME >
Company List >
LTT Bio-Pharma (Annual ): Financial Outline Report

Financial Outline Report: Annual; First quarter; Second quarter; Third quarter

Sponsored Link

Related Company: New Japan Chemical; 廣貫堂; LTT Bio-Pharma; 日本化学工業; KOEI CHEMICAL; Carna Biosciences; Nippon Shikizai; 小野産業; ダイトーケミックス; Kawaguchi Chemical Industry

EDIUNET Related Ranking: EDIUNET; EDIUNET Credit Rating; EDIUNET Industry Avg; EDIUNET Prefectures; Yuho! Industry

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

10/30 Real Estate (DAIBIRU:BBB→A e..

RSS

Company RSS

Daily RSS

Sponsored Link

Recently Download Chart: KIKUSUI ELECTRONICS etc.

KIKUSUI ELECTRONICS etc.

ROHM

Yushiro Chemical Indutry

NITCHITSU

Financial Outline Report: LTT Bio-Pharma (Annual )

It is a free Financial Outline Report which can grasp intuitively a financial statement summary , a corporate value, credit rating, etc. by various charts.Two or more companies can be compared and various charts can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Summary: LTT Bio-Pharma (Annual )

Credit Rating (Bankruptcy Risk) Consolidated | Non-Consolidated

Date	Credit Rating	Comment	Sales	Current Profit	Net Income
2012-03-31	C	Credit is extremely vulnerable. The lowest rating.	¥ 61 M -40.04%	¥ -65 M 73.55%	¥ -66 M 84.87%

Financial Timeline

Date	- (First quarter )	2010-12-31 (Third quarter )	2011-09-30 (Second quarter )	2012-03-31 (Annual )
Credit Rating	-	BBB	BB	C
Total Assets	-	¥ 1 B	¥ 1 B	¥ 401 M
Net Assets	-	¥ 1 B	¥ 795 M	¥ 802 M

Net sales has dropped 4 consecutive terms. The business have high risk.

The change of Net income is going too far. The management situation is unstable.

Operating cash flow minus 4 consecutive terms. The business have very high risk.

Date	Credit Rating	Comment	Sales	Current Profit	Net Income
2013-03-31	BBB	Credit is enough, but be decreased potential by biz environs.	¥ 67 M 10.35%	¥ 147 M 326.32%	¥ 116 M 275.16%

Date	- (First quarter )	- (Third quarter )	2011-09-30 (Second quarter )	2013-03-31 (Annual )
Credit Rating	-	-	-	BBB
Total Assets	-	-	¥ 1 B	¥ 954 M
Net Assets	-	-	¥ 795 M	¥ 923 M

Financial Chart Download

Financial Timeline Chart

Financial Statement Details

Indicator Comparison Chart

Financial Indicator Details

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31
Net profit margin (Industry Average)	-1.11% (-0.50%)	45.58% (1.53%)	-428.06% (-1.67%)	-107.97% (3.05%)
C/F margin (Industry Average)	-28.49% (8.51%)	-221.10% (7.04%)	-72.58% (6.35%)	-95.63% (8.25%)
ROA (Industry Average)	-0.91% (1.04%)	3.50% (2.07%)	-47.90% (0.06%)	- (2.71%)
ROE (Industry Average)	-1.11% (0.03%)	3.63% (2.96%)	-50.58% (4.68%)	-8.26% (4.57%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31
Equity growth (Industry Average)	- (5.01%)	3.77% (2.61%)	-33.79% (-0.40%)	-7.47% (8.16%)
Sales growth (Industry Average)	- (-)	-91.70% (5.36%)	-1.95% (1.07%)	-40.04% (2.24%)
Net profit growth (Industry Average)	- (203.46%)	438.41% (63.25%)	-1,020.71% (3.89%)	84.87% (90.38%)
Operating C/F growth (Industry Average)	- (275.10%)	35.65% (35.09%)	67.81% (-6.09%)	21.00% (138.39%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31
Capital adequacy (Industry Average)	81.94% (54.51%)	96.26% (55.00%)	94.71% (53.59%)	- (56.30%)
Liquidity ratio (Industry Average)	304.98% (225.70%)	1,884.05% (237.55%)	2,145.19% (239.89%)	- (236.21%)
C/F ratio current liabilities (Industry Average)	-73.27% (303.31%)	-17.32% (434.79%)	-53.66% (929.73%)	1,365.60% (573.30%)
Quick ratio (Industry Average)	297.53% (148.85%)	1,472.91% (156.17%)	1,998.18% (160.84%)	- (156.81%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31
Receivables turnover (Industry Average)	9.08day (94.27day)	79.99day (93.96day)	40.59day (97.92day)	- (98.27day)
Inventory turnover (Industry Average)	- (52.58day)	- (52.64day)	- (56.59day)	- (58.68day)
Payable turnover (Industry Average)	0.16day (49.82day)	3.90day (49.52day)	5.59day (52.10day)	- (51.12day)
Working capita turnover (Industry Average)	8.92day (97.02day)	76.09day (97.08day)	35.00day (102.41day)	- (105.83day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31
Market Value growth (Industry Average)	- (34.57%)	281.57% (1.49%)	-70.41% (-3.85%)	- (21.16%)
Dividend Yield (Industry Average)	- (1.93%)	- (2.17%)	- (2.45%)	- (2.07%)
PER (Industry Average)	-87.47% (23.06%)	98.62% (16.22%)	-3.16% (29.19%)	- (16.58%)
PBR (Industry Average)	0.97% (1.06%)	3.58% (1.04%)	1.60% (0.95%)	- (1.08%)
PCFR (Industry Average)	-3.42% (9.23%)	-20.33% (-2.43%)	-18.69% (9.50%)	- (7.56%)
PSR (Industry Average)	0.97% (0.88%)	44.95% (1.10%)	13.56% (0.90%)	- (1.01%)

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	200.10% (-27.66%)	144.33% (-4.34%)	-1,183.26% (-5.37%)	-108.41% (-10.69%)	172.09% (8.92%)
C/F margin (Industry Average)	- (0.87%)	- (1.04%)	- (0.82%)	- (-0.81%)	196.82% (-39.63%)
ROA (Industry Average)	3.20% (0.52%)	6.01% (0.92%)	-52.11% (1.42%)	-8.10% (-0.27%)	12.18% (1.53%)
ROE (Industry Average)	3.91% (-0.84%)	6.23% (-0.46%)	-54.91% (1.81%)	-8.26% (3.42%)	12.59% (2.62%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	6.65% (3.64%)	-35.64% (3.03%)	-7.47% (0.04%)	15.01% (3.91%)
Sales growth (Industry Average)	- (-)	135.68% (-3.48%)	-30.87% (6.70%)	52.01% (0.75%)	10.35% (-1.74%)
Net profit growth (Industry Average)	- (-)	69.99% (166.48%)	-666.72% (43.48%)	86.07% (-47.04%)	275.16% (62.14%)
Operating C/F growth (Industry Average)	- (-)	- (89.80%)	- (77.44%)	- (-44.41%)	- (46.89%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	81.96% (56.79%)	96.42% (57.65%)	94.89% (57.17%)	98.07% (55.93%)	96.73% (57.57%)
Liquidity ratio (Industry Average)	304.51% (337.22%)	1,859.56% (276.75%)	2,173.53% (266.94%)	9,999.64% (314.47%)	4,022.98% (233.84%)
C/F ratio current liabilities (Industry Average)	- (48.90%)	- (53.10%)	- (31.35%)	- (76.77%)	16.70% (31.87%)
Quick ratio (Industry Average)	291.12% (167.28%)	1,432.41% (183.78%)	2,023.14% (174.83%)	9,682.17% (228.06%)	3,931.21% (169.77%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	231.66day (87.55day)	- (98.39day)	6.79day (95.88day)	- (98.58day)	- (67.18day)
Inventory turnover (Industry Average)	- (50.17day)	- (48.43day)	- (47.43day)	- (50.67day)	- (38.21day)
Payable turnover (Industry Average)	8.18day (45.70day)	4.05day (51.63day)	- (51.13day)	- (53.57day)	- (34.24day)
Working capita turnover (Industry Average)	223.48day (92.02day)	-4.05day (95.19day)	6.79day (92.19day)	- (95.69day)	- (71.15day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	281.57% (34.46%)	-70.41% (3.11%)	- (-3.30%)	- (24.19%)
Dividend Yield (Industry Average)	- (0.15%)	- (0.09%)	- (0.10%)	- (0.16%)	- (0.15%)
PER (Industry Average)	24.91% (34.12%)	55.91% (27.80%)	-2.91% (13.58%)	- (22.26%)	- (26.42%)
PBR (Industry Average)	0.97% (0.97%)	3.48% (1.21%)	1.60% (1.17%)	- (1.08%)	- (1.54%)
PCFR (Industry Average)	- (0.27%)	- (0.62%)	- (0.23%)	- (0.08%)	- (4.97%)
PSR (Industry Average)	49.84% (3.42%)	80.70% (4.34%)	34.54% (3.67%)	- (4.37%)	- (10.14%)

Corporate value chart

Enterprise Value	2009-03-31	2010-03-31	2011-03-31	2012-03-31
Market Value	¥ 1 B (1)	¥ 4 B (1)	¥ 1 B (1)	- (1)
Net Value	¥ 1 B (0.98)	¥ 1 B (3.59)	¥ 867 M (1.6)	¥ 802 M (1)
Returns Value	¥ -142 M (- )	¥ 476 M (9.86)	¥ -4 B (- )	¥ -397 M (- )
Dividend Value	- (- )	- (- )	- (- )	- (- )
Enterprise Value	¥ 479 M (2.57)	¥ 4 B (1.14)	¥ 604 M (2.3)	- (- )

Enterprise Value	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value	¥ 1 B (1)	¥ 4 B (1)	¥ 1 B (1)	- (1)	- (1)
Net Value	¥ 1 B (0.97)	¥ 1 B (3.49)	¥ 867 M (1.6)	¥ 802 M (1)	¥ 923 M (1)
Returns Value	¥ 999 M (1.23)	¥ 2 B (2.24)	¥ -3 B (- )	¥ -995 M (- )	¥ 1 B (0.72)
Dividend Value	- (- )	- (- )	- (- )	- (- )	- (- )
Enterprise Value	¥ 481 M (2.56)	¥ 4 B (1.14)	¥ 619 M (2.25)	- (- )	- (- )

Related Information: LTT Bio-Pharma (Annual )

Statement Type: Annual : LTT Bio-Pharma; Second quarter : LTT Bio-Pharma; Third quarter : LTT Bio-Pharma

Analysis Menu: Outline : LTT Bio-Pharma; Statement : LTT Bio-Pharma; Rating : LTT Bio-Pharma; Indicator : LTT Bio-Pharma; Download : LTT Bio-Pharma

Industry Comparison Ranking: Chemicals - EDIUNET Industry Rankings; Chemicals - EDIUNET Credit Rating; Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company: Tokyo - EDIUNET Prefectures; Tokyo港区 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals): 1/23 Chemicals (Milbon:AA→AAA); 1/17 Chemicals (Kawaguchi Chemica..; 1/15 Chemicals (HOKKO CHEMICAL IN..; 1/10 Chemicals (OSAKA ORGANIC CHE..; 1/9 Chemicals (SANKO GOSEI:A); 12/27 Chemicals (Niitaka:A); 12/18 Chemicals (KUMIAI CHEMICAL I..; 12/12 Chemicals (IHARA CHEMICAL IN..; 12/11 Chemicals (Konoshima Chemica..; 12/10 Chemicals (NATOCO:AA)

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .

▲ Go to the top ▲

HOME >
Company List >
LTT Bio-Pharma (Annual ): Financial Outline Report

EDIUNET Rating News

Screening Search

Member limited service

Company Search
- [close]
  
  [keyword]
  
  Company Search
  
  *It can search to each item of a type of industry, a stock market, the settlement-of-accounts moon, and a keyword.
  
  *Top 30 search results are displayed.
  
  [close]

Company Ranking

Free equity investment tool of Japanese companies

Financial Outline Report: LTT Bio-Pharma (Annual )

Summary: LTT Bio-Pharma (Annual )

Credit Rating (Bankruptcy Risk) Consolidated | Non-Consolidated

Financial Timeline

Credit Rating (Bankruptcy Risk) Consolidated | Non-Consolidated

Financial Timeline

Financial Chart Download

Financial Timeline Chart

Indicator Comparison Chart

Consolidated :Indicator Consolidated | Non-Consolidated

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Corporate value chart

Related Information: LTT Bio-Pharma (Annual )

Related company's newest statement

Related Company

関連する株式投資情報

EDIUNET Caution